Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Health and Safety Executive Warns Employers About The Safety Of Equipment After Worker's Hand Is Damaged By Rotating Blades, UK
The Health and Safety Executive (HSE) is warning employers to ensure they assess the safety of equipment and ensure that it is sufficiently guarded after an employee"s left hand was severely damaged by the rotating blades of a valve that forms part of the extraction system in a metal recycling process.
generic viagra online
Rapid, Pain-Free Test For Men Offered By New Chlamydia Test
A new urine test developed with funding from the Wellcome Trust will allow doctors to diagnose Chlamydia infection in men within the hour, improving the ability to successfully treat the infection on the spot and prevent re-transmission.
News of the day
Study Looks At HIV, Risk Behaviors Among Male Clients Of Sex Workers In Tijuana, Mexico
"A large percentage" of U.S. and Mexican men who regularly engage in sexual activity with sex workers in Tijuana, Mexico, do not use condoms and have a history of substance and alcohol use, according to a study published in the online journal AIDS, the Los Angeles Times" blog "L.A. Now" reports. The study, by researchers from Mexico and the University of California-San Diego, surveyed 400 men - both Mexico and U.S. residents - and found that half of the men had unprotected sex with a female sex worker within the last four months. Researchers noted that although Tijuana authorities require that sex workers be registered and tested regularly for HIV, "only about half of [sex workers] have registered or been tested," according to the blog. Thomas Patterson of the UC-San Diego"s department of psychiatry and the Veterans Affairs health center, said the findings indicate a need for an educational campaign targeting men who frequent sex workers (Perry, 7/11).
Sexual Health

Cytokinetics To Present Phase IIa Clinical Trials Data On CK-1827452 At The 2009 Heart Failure Congress Of The European Society Of Cardiology

Cytokinetics, Incorporated (NASDAQ: CYTK) announced that data relating to two Phase IIa clinical trials evaluating CK-1827452, one in stable heart failure patients and one in patients with ischemic cardiomyopathy and angina, are scheduled to be presented in two poster presentations and in the late breaking trials session at the 2009 Heart Failure Congress of the European Society of Cardiology, to be held May 30-June 2, 2009, at the Nice Acropolis Palais des Congrç¨s et Expositions in Nice, France. Late Breaking Trials Session The late breaking presentation titled "The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in Heart Failure" will be presented on Monday, June 1, 2009 from 11:00 AM - 12:30 PM Central European Time in the Apollon Auditorium by John Cleland, MD, FACC, FRCP, FESC, Professor of Cardiology, Castle Hill Hospital, University of Hull, United Kingdom. Poster Presentations Program #149: "Echocardiographic Detection of Increases in Ejection Fraction in Patients with Heart Failure Receiving the Selective Cardiac Myosin Activator, CK-1827452" is scheduled to be displayed in the session titled "Medical and Surgical Treatments Poster Session: Drug Therapy, Other" on Sunday, May 31, 2009 from 8:30 AM - 12:30 PM Central European Time in the Clinical Poster Zone. The poster will be moderated by Jonathan H. Goldman, MD, FACC, Chief Medical Officer, ICON Medical Imaging, Warrington, PA from 10:00 AM - 11:00 AM. Program #174: "Phase II Safety Study Evaluating the Novel Cardiac Myosin Activator, CK-1827452, in Patients with Ischemic Cardiomyopathy and Angina" is scheduled to be displayed in the session titled "Medical and Surgical Treatments Poster Session: Drug Therapy, Other" on Sunday, May 31, 2009 from 8:30 AM - 12:30 PM Central European Time in the Clinical Poster Zone. The poster will be moderated by Barry H. Greenberg, MD, Chair of the Safety Review Committee for this clinical trial and Director, Advanced Heart Failure Treatment Program, University of California, San Diego Medical Center from 10:00 AM - 11:00 AM. Cytokinetics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009